NCT00488345 - Study Evaluating the Pharmacokinetics (PK), Safety, and Tolerability of Tigecycline in Patients 8 to 11 Years of Age | Biotech Hunter

Enrollment

Participants

Timeline

Start Date

December 31, 2007

Primary Completion Date

September 30, 2009

Study Completion Date

September 30, 2009

Conditions

Bacterial InfectionsIntra-Abdominal InfectionPneumonia, BacterialSkin Diseases, BacterialSkin Diseases, Infectious

Interventions

DRUG

Tygacil

Trial Locations (36)

100

Taipei

1090

Brussels

1200

Brussels

4209

Kyiv

6850

Worcester

7500

Parow

10032

New York

15213

Pittsburgh

19104

Philadelphia

21021

Vinnitsa

23298

Richmond

27710

Durham

33606

Tampa

39218

Jackson

40202

Louisville

44308

Akron

48503

Flint

49100

Dnipropetrovsk

61098

Kharkiv

68131

Omaha

79085

Lviv

84108

Salt Lake City

88000

Uzhhorod

90806

Long Beach

92123

San Diego

92868

Orange

94609

Oakland

45229-3039

Cincinnati

17033-0850

Hershey

0000

Guadalarajara Jalisco

0001

Pretoria

00082

Pretoria

00040

Themba

0.0405

Kyiv

0.1133

Kyiv

All Listed Sponsors

lead

Wyeth is now a wholly owned subsidiary of Pfizer

INDUSTRY